Fungal biocontrol
Pith reviewed 2026-05-21 00:32 UTC · model grok-4.3
The pith
Artificially infecting a host plant with the deposited strain Beauveria bassiana O 2380 produces measurable resistance to fungal disease.
A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.
Core claim
The central claim is that artificial infection of a host plant with the specific strain B. bassiana O 2380 (DSM 33860) creates a host plant/B. bassiana combination that confers at least some level of resistance to fungal disease.
What carries the argument
The deposited strain B. bassiana O 2380 (DSM 33860) introduced by artificial infection to establish an endophytic or epiphytic association inside or on the plant.
If this is right
- The treated plant expresses reduced symptoms or lower pathogen load when later exposed to compatible fungal pathogens.
- The same strain can be applied to multiple host species to generate similar protective combinations.
- Once the combination is formed, the resistance persists without continuous re-application of the fungus.
- The method provides an alternative to synthetic fungicides for at least some economically important diseases.
Where Pith is reading between the lines
- Farmers could treat seedlings once and obtain season-long protection, lowering chemical inputs and residue concerns.
- The deposited strain might be combined with other beneficial microbes to create multi-purpose seed or transplant treatments.
- If the resistance holds under commercial field conditions, regulators could evaluate the strain as a new biocontrol active ingredient.
Load-bearing premise
The chosen strain must actually reduce disease severity in at least one crop species under ordinary growing conditions.
What would settle it
A controlled greenhouse or field trial that compares disease incidence or severity on plants inoculated with DSM 33860 versus uninoculated controls of the same cultivar, using a measurable pathogen such as Fusarium or Botrytis.
read the original abstract
1 . A method of conferring at least some level of fungal disease resistance on a host plant comprising artificially infecting the host plant with an isolated strain of B. bassiana O 2380, representative sample having been deposited under accession DSM 33860 at Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, to form a host plant/ B. bassiana combination.
Editorial analysis
A structured set of objections, weighed in public.
Referee Report
Summary. The manuscript presents a single method claim for conferring fungal disease resistance on a host plant by artificial infection with the deposited Beauveria bassiana strain O 2380 (DSM 33860), forming a host plant/B. bassiana combination.
Significance. If substantiated, the approach could contribute to biological control of fungal plant pathogens. However, the filing supplies no experimental results, infection protocols, pathogen-challenge data, disease metrics, or controls, so the asserted phenotype remains unsupported.
major comments (1)
- Abstract/Claim 1: The assertion that infection with B. bassiana DSM 33860 confers 'at least some level of fungal disease resistance' is presented without any supporting infection protocol, host species, challenge pathogen, disease severity scoring, or control data, rendering the central utility claim unsubstantiated.
Simulated Author's Rebuttal
We thank the referee for the careful reading. This document is a patent application whose enablement rests on the deposited strain together with the ordinary skill in the art for establishing Beauveria endophytes. We address the single substantive comment below.
read point-by-point responses
-
Referee: Abstract/Claim 1: The assertion that infection with B. bassiana DSM 33860 confers 'at least some level of fungal disease resistance' is presented without any supporting infection protocol, host species, challenge pathogen, disease severity scoring, or control data, rendering the central utility claim unsubstantiated.
Authors: We agree that the application contains no new experimental results. Patent enablement for a method claim using a deposited microorganism is satisfied when the specification (here the deposit itself) together with the knowledge of a person skilled in the art permits practice of the invention without undue experimentation. Beauveria bassiana is already known to form asymptomatic endophytic associations in many plants; the novelty resides in the particular strain and the resulting resistance phenotype. Standard inoculation techniques (seed coating, root drench, foliar spray) are routine in the field and do not require further exemplification for claim scope. Nevertheless, if the examiner requires it, a brief description of representative inoculation conditions can be added to the specification. revision: partial
- Absence of any wet-lab data, disease metrics, or controls for the asserted resistance phenotype
Circularity Check
No derivation chain present; method claim only
full rationale
The document is a patent claiming a method of plant infection with deposited B. bassiana strain DSM 33860. It contains no equations, fitted parameters, predictions, first-principles derivations, or self-citations that could reduce to inputs by construction. The sole load-bearing assertion is biological efficacy, which is stated rather than derived, so no circularity analysis applies.
discussion (0)
Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.